Leerink Partnrs Weighs in on Cardinal Health, Inc.’s Q4 2024 Earnings (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAH) – Research analysts at Leerink Partnrs dropped their Q4 2024 EPS estimates for shares of Cardinal Health in a report issued on Thursday, May 2nd. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings per share of $1.75 for the quarter, down from their prior estimate of $1.79. Leerink Partnrs currently has a “Outperform” rating on the stock. The consensus estimate for Cardinal Health’s current full-year earnings is $7.34 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q1 2025 earnings at $1.72 EPS, Q2 2025 earnings at $1.82 EPS, Q3 2025 earnings at $2.10 EPS, FY2025 earnings at $7.60 EPS, FY2026 earnings at $8.41 EPS, FY2027 earnings at $9.22 EPS and FY2028 earnings at $10.05 EPS.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.13. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The firm had revenue of $54.90 billion during the quarter, compared to the consensus estimate of $56.05 billion. During the same period last year, the firm posted $1.74 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis.

A number of other analysts have also commented on the company. Robert W. Baird decreased their price objective on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating on the stock in a research note on Friday. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Thursday. UBS Group raised their target price on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Wells Fargo & Company cut their price target on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research note on Monday, April 29th. Finally, Evercore ISI boosted their price objective on shares of Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a research note on Friday. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $105.79.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $98.91 on Monday. Cardinal Health has a one year low of $77.56 and a one year high of $116.04. The stock has a market cap of $24.06 billion, a PE ratio of 43.96, a price-to-earnings-growth ratio of 0.99 and a beta of 0.71. The business’s fifty day moving average price is $109.10 and its two-hundred day moving average price is $105.09.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date of this dividend was Thursday, March 28th. Cardinal Health’s dividend payout ratio is presently 88.89%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Aaron Wealth Advisors LLC increased its position in Cardinal Health by 1.2% in the 4th quarter. Aaron Wealth Advisors LLC now owns 8,369 shares of the company’s stock valued at $844,000 after acquiring an additional 97 shares during the period. Schechter Investment Advisors LLC increased its holdings in shares of Cardinal Health by 4.1% during the fourth quarter. Schechter Investment Advisors LLC now owns 2,480 shares of the company’s stock valued at $250,000 after purchasing an additional 98 shares during the period. J. W. Coons Advisors LLC increased its holdings in shares of Cardinal Health by 0.6% during the fourth quarter. J. W. Coons Advisors LLC now owns 16,680 shares of the company’s stock valued at $1,681,000 after purchasing an additional 100 shares during the period. Edmonds Duncan Registered Investment Advisors LLC raised its stake in shares of Cardinal Health by 5.0% during the first quarter. Edmonds Duncan Registered Investment Advisors LLC now owns 2,090 shares of the company’s stock valued at $234,000 after purchasing an additional 100 shares in the last quarter. Finally, Cypress Capital Group lifted its holdings in Cardinal Health by 0.7% in the third quarter. Cypress Capital Group now owns 17,133 shares of the company’s stock worth $1,487,000 after purchasing an additional 111 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.